Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA).

Karim Makdoumi, Anders Bäckman, Jes Mortensen, Sven Crafoord
Author Information
  1. Karim Makdoumi: Department of Ophthalmology, Orebro University Hospital, Orebro, Sweden. karim.makdoumi@orebroll.se

Abstract

BACKGROUND: To evaluate the antibacterial efficacy of photo-activated riboflavin using Ultraviolet A (UVA) on three bacterial strains commonly detected in keratitis.
METHODS: Three bacterial strains (Staphylococcus epidermidis, Staphylococcus aureus and Pseudomonas aeruginosa) were cultured on blood/hematin-agar plates and dispersed in PBS. Dispersion was done of 10 microl of bacterial stock-solutions in 90 microl of RPMI, where different riboflavin molarities had been added, to achieve a bacterial concentration of 1-4 x 10 (4)/ml. Riboflavin end molarities before illumination were 0, 100, 200, 300 and 400 microM. Each solution had a negative control. The solutions were illuminated with UVA (365 nm) for 30 minutes (5.4 J/cm(2)) and then continued for a total time of 60 minutes (10.8 J/cm(2)). A count of CFU was conducted after incubation and results compared.
RESULTS: In all tested strains, a slight decrease of bacteria was seen when exposed to UV for 30 minutes. A doubling of the UV dose showed a marked decrease of bacterial count in all bacteria tested. The combination of UV and riboflavin showed a more extensive reduction of CFU, confirming an interaction effect between UV and riboflavin.
CONCLUSION: Riboflavin photo-activation using UVA (365 nm) can achieve an extensive eradication of bacteria, and the combination is more potent in reducing bacterial number than UV alone.

References

  1. Transfusion. 2008 Aug;48(8):1685-92 [PMID: 18513255]
  2. Clin Exp Ophthalmol. 2006 Jan-Feb;34(1):3-5 [PMID: 16451250]
  3. Transfus Apher Sci. 2006 Aug;35(1):5-17 [PMID: 16935562]
  4. Transfusion. 2004 Jun;44(6):877-85 [PMID: 15157255]
  5. Expert Opin Investig Drugs. 2008 Mar;17(3):297-302 [PMID: 18321229]
  6. Am J Med. 2006 Jun;119(6 Suppl 1):S29-36; discussion S62-70 [PMID: 16735148]
  7. Transfus Med Rev. 2008 Apr;22(2):133-53 [PMID: 18353253]
  8. Curr Opin Ophthalmol. 2006 Aug;17(4):356-60 [PMID: 16900027]
  9. Vox Sang. 2006 Feb;90(2):85-91 [PMID: 16430665]
  10. J Cataract Refract Surg. 2008 May;34(5):796-801 [PMID: 18471635]
  11. Klin Monbl Augenheilkd. 2000 Sep;217(3):190-3 [PMID: 11076351]
  12. J Cataract Refract Surg. 2007 Nov;33(11):1978-81 [PMID: 17964409]
  13. Am J Ophthalmol. 2003 May;135(5):620-7 [PMID: 12719068]
  14. Cornea. 2007 Aug;26(7):891-5 [PMID: 17667633]
  15. Biochim Biophys Acta. 1965 Jun 8;103(2):360-3 [PMID: 5319746]
  16. J Refract Surg. 2009 Apr;25(4):371-6 [PMID: 19431928]
  17. J Refract Surg. 2008 Sep;24(7):S720-5 [PMID: 18811118]
  18. Ophthalmic Res. 2009;42(1):43-8 [PMID: 19478540]
  19. Photochem Photobiol. 2004 Jul-Aug;80:15-21 [PMID: 15339215]
  20. J Cataract Refract Surg. 2007 Jul;33(7):1318-21 [PMID: 17586393]
  21. Eur J Ophthalmol. 2009 Mar-Apr;19(2):295-7 [PMID: 19253251]
  22. J Cataract Refract Surg. 2006 May;32(5):837-45 [PMID: 16765803]
  23. J Cataract Refract Surg. 2007 Nov;33(11):1831-2 [PMID: 17964369]
  24. Pharmacotherapy. 2008 Feb;28(2):235-49 [PMID: 18225969]
  25. J Cataract Refract Surg. 2007 Dec;33(12):2035-40 [PMID: 18053900]
  26. Ophthalmology. 2009 Mar;116(3):369-78 [PMID: 19167087]
  27. Cornea. 2008 Jun;27(5):590-4 [PMID: 18520510]
  28. Expert Rev Anti Infect Ther. 2008 Feb;6(1):39-49 [PMID: 18251663]
  29. Transfusion. 2005 Jun;45(6):911-9 [PMID: 15934989]
  30. J Cataract Refract Surg. 2007 Aug;33(8):1488-9 [PMID: 17662450]
  31. Transfus Apher Sci. 2007 Oct;37(2):131-7 [PMID: 17950672]
  32. J Cataract Refract Surg. 2006 Mar;32(3):515-8 [PMID: 16631067]
  33. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3402-8 [PMID: 18408193]
  34. Transfusion. 2005 Aug;45(8):1335-41 [PMID: 16078923]
  35. Int J Hematol. 2002 Aug;76 Suppl 2:253-7 [PMID: 12430933]

MeSH Term

Anti-Bacterial Agents
Colony Count, Microbial
Humans
Keratitis
Photosensitizing Agents
Pseudomonas Infections
Pseudomonas aeruginosa
Riboflavin
Staphylococcal Infections
Staphylococcus aureus
Staphylococcus epidermidis
Ultraviolet Rays

Chemicals

Anti-Bacterial Agents
Photosensitizing Agents
Riboflavin

Word Cloud

Created with Highcharts 10.0.0bacterialriboflavinUVUVAusingstrains10minutesbacteriaantibacterialefficacyphoto-activatedStaphylococcusmicrolmolaritiesachieve4Riboflavin365nm30J/cm2countCFUtesteddecreaseshowedcombinationextensiveBACKGROUND:evaluateUltravioletthreecommonlydetectedkeratitisMETHODS:ThreeepidermidisaureusPseudomonasaeruginosaculturedblood/hematin-agarplatesdispersedPBSDispersiondonestock-solutions90RPMIdifferentaddedconcentration1-4x/mlendillumination0100200300400microMsolutionnegativecontrolsolutionsilluminated5continuedtotaltime608conductedincubationresultscomparedRESULTS:slightseenexposeddoublingdosemarkedreductionconfirminginteractioneffectCONCLUSION:photo-activationcaneradicationpotentreducingnumberaloneEvaluationultravioletlight

Similar Articles

Cited By